SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings & Portfolio

CIK 1931118 · latest 13F-HR filed 2026-08-14

SUPERSTRING CAPITAL MANAGEMENT LP manages $158.4M in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are COGT (8.39%), AXSM (8.33%), GMAB (7.47%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 8 new positions and exited 11; 14 existing positions rose in reported value and 8 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$158.4M

Long-equity book

Holdings
32

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+8 / −11 / ↑14 / ↓8

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 63.8%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 30, 2026.

Assets Under Management
$339.5M
Discretionary
$339.5M
Employees
5
Accounts
6
Address
150 E 52ND ST
SUITE 5004
NEW YORK, NY 10022
Phone
(212) 257-5690
Name Title / Status Ownership Type
DOHERTY, MARK, PETER ControlCHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER
since Mar 2026
Less than 5%Individual
SUPERSTRING CAPITAL FUND GP LLC ControlGENERAL PARTNER
since Oct 2019
Less than 5%Domestic Entity
Ting, Guo ControlMANAGING PARTNER
since Oct 2019
75% or moreIndividual
Ting, Guo Control
Indirect owner via SUPERSTRING CAPITAL FUND GP LLC
MANAGING PARTNER
since Oct 2019
75% or moreIndividual
Ownership & leadership changes · 2 filings with changes since Oct 18, 2019

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 30, 2026 filing
  • No longer listedSONG, GEORGE, BENEDICT · CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER · Less than 5% · control person · listed since Oct 2019
  • AddedDOHERTY, MARK, PETER · CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER · Less than 5% · control person
Apr 20, 2020 filing
  • ChangedSUPERSTRING CAPITAL FUND GP LLC · ownership 75% or more → Less than 5%
Oct 18, 2019 filing (earliest on record)
  • ListedSONG, GEORGE, BENEDICT · CHIEF COMPLIANCE OFFICER, CHIEF OPERATING OFFICER, CHIEF FINANCIAL OFFICER · Less than 5% · control person
  • ListedSUPERSTRING CAPITAL FUND GP LLC · GENERAL PARTNER · 75% or more · control person
  • ListedTing, Guo · MANAGING PARTNER · 75% or more · control person
  • ListedTing, Guo · MANAGING PARTNER · 75% or more · indirect via SUPERSTRING CAPITAL FUND GP LLC · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

SUPERSTRING CAPITAL MANAGEMENT LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 COGENT BIOSCIENCES INC COGT 19240Q201 $13.3M 8.39% 343,284 SH
2 AXSOME THERAPEUTICS INC. AXSM 05464T104 $13.2M 8.33% 53,916 SH
3 GENMAB A/S GMAB 372303206 $11.8M 7.47% 430,600 SH
4 CELLDEX THERAPEUTICS INC NEW CLDX 15117B202 $10.7M 6.76% 287,583 SH
5 TREVI THERAPEUTICS INC TRVI 89532M101 $9.8M 6.17% 524,224 SH
6 REVOLUTION MEDICINES INC RVMD 76155X100 $9.6M 6.04% 51,053 SH
7 DEFINIUM THERAPEUTICS INC DFTX 24477V105 $8.9M 5.59% 188,282 SH
8 VIR BIOTECHNOLOGY INC VIR 92764N102 $8.7M 5.49% 853,685 SH
9 IMMUNOVANT INC IMVT 45258J102 $8.0M 5.07% 208,368 SH
10 UROGEN PHARMA LTD URGN M96088105 $7.0M 4.45% 191,313 SH
11 CLIMB BIO INC CLYM 28658R106 $6.8M 4.29% 521,082 SH
12 ADLAI NORTYE LTD ANL 00704R109 $6.4M 4.01% 552,501 SH
13 SAVARA INC SVRA 805111101 $6.0M 3.80% 977,460 SH
14 MAPLIGHT THERAPEUTICS INC MPLT 56565P103 $4.5M 2.84% 125,432 SH
15 ORIC PHARMACEUTICALS INC ORIC 68622P109 $4.4M 2.78% 406,077 SH
16 UNITED THERAPEUTICS CORP DEL UTHR 91307C102 $3.9M 2.45% 7,172 SH
17 VAXCYTE INC PCVX 92243G108 $3.9M 2.45% 66,793 SH
18 BEONE MEDICINES LTD ONC 07725L102 $3.5M 2.21% 12,273 SH
19 CABALETTA BIO INC CABA 12674W109 $3.5M 2.20% 1,278,652 SH
20 ZAI LAB LTD ZLAB 98887Q104 $3.0M 1.87% 155,813 SH
21 SIONNA THERAPEUTICS INC SION 829401108 $2.8M 1.75% 63,156 SH
22 BRIGHT MINDS BIOSCIENCES INC DRUG 10919W405 $2.1M 1.35% 30,456 SH
23 ACLARIS THERAPEUTICS INC ACRS 00461U105 $1.4M 0.86% 257,675 SH
24 CYBIN INC HELP 23256X407 $1.4M 0.85% 204,424 SH
25 KINIKSA PHARMACEUTICALS INTL KNSA G52694109 $1.2M 0.76% 18,867 SH
26 ROIVANT SCIENCES LTD ROIV G76279101 $906.8K 0.57% 25,623 SH
27 TONIX PHARMACEUTICALS HLDG C TNXP 890260839 $812.1K 0.51% 63,648 SH
28 PROTARA THERAPEUTICS INC TARA 74365U107 $464.0K 0.29% 121,457 SH
29 FAETH THERAPEUTICS INC FTH 81728A207 $354.4K 0.22% 14,175 SH
30 BOUNDLESS BIO INC BOLD 10170A100 $138.4K 0.09% 55,356 SH
31 BIOMEA FUSION INC BMEA 09077A106 $85.3K 0.05% 250,000 SH
32 VYNE THERAPEUTICS INC VYNE 92941V308 $39.9K 0.03% 61,269 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $158.4M 32 0001931118-26-000009
2026-03-31 2026-05-14 $140.0M 35 0001931118-26-000008
2025-12-31 2026-02-17 $186.8M 45 0001931118-26-000003
2025-09-30 2025-11-14 $101.5M 35 0001931118-25-000010
Filer Information
Address
150 E. 52ND ST
SUITE 5004
NEW YORK, NY 10022
Phone
(212) 257-5690
Filing Manager
SUPERSTRING CAPITAL MANAGEMENT LP
NEW YORK, NY
Signatory
Mark Doherty
COO